PharmaResources (Shanghai) Co., Ltd. (SHE:301230)
China · Delayed Price · Currency is CNY 37.09
+1.92 (5.46%)
At close: Jun 23, 2026
SHE:301230 Market Cap
SHE:301230 has a market cap or net worth of 4.84 billion as of June 23, 2026. Its market cap has increased by 9.70% in one year.
Market Cap
4.84B
Enterprise Value
4.71B
Revenue
691.21M
Ranking
n/a
PE Ratio
110.32
Stock Price
37.09
Market Cap Chart
Since November 1, 2022, SHE:301230's market cap has increased from 3.94B to 4.84B, an increase of 22.83%. That is a compound annual growth rate of 5.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 22, 2026 | 4.84B | 17.74% |
| Dec 31, 2025 | 4.11B | 17.05% |
| Dec 31, 2024 | 3.51B | -8.90% |
| Dec 29, 2023 | 3.85B | -6.18% |
| Dec 30, 2022 | 4.11B | 4.27% |
| Nov 1, 2022 | 3.94B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shanghai OPM Biosciences | 5.30B |
| Jiangsu Aidea Pharmaceutical Group | 5.29B |
| Anhui Huaheng Biotechnology | 5.20B |
| Shanghai Serum Bio-Technology | 5.17B |
| Novogene | 5.06B |
| Shenzhen Weiguang Biological Products | 5.03B |
| Shouyao Holdings (Beijing) Co., LTD. | 4.82B |
| Wuhan Hvsen Biotechnology | 4.69B |